Infectious complications following T-cell depleted hematopoietic stem-cell transplantation
- 1 May 2001
- journal article
- clinical trial
- Published by Elsevier in Cytotherapy
- Vol. 3 (3) , 165-173
- https://doi.org/10.1080/146532401753173990
Abstract
Although sepsis is a common complication during stem-cell transplantation, the prevalence of infections after hematopoietic recovery is less well known. We undertook a retrospective analysis of infectious episodes in patients who underwent allogeneic BM (n = 77) or PBS C (n = 29) graftingfrom HLA identical siblings. T-cell depletion of the stem-cell grafts with anti CD 52 (CAMPA TH-1) Abs was employed for the prevention ofGvHD. Patients' median age was 30 (4–54) years. Antibiotic prophylaxis was with oral amphotericin, ofloxacin and i.v. or oral acyclovir. Fever was treated empirically with a third generation cephalosporin and aminoglucosides until results of microbiological cultures became available. Six patients died of graft failure. GvHD was observed in 18% but in no case was it > Grade II. Only seven patients did not develop pyrexia during the initial admission or within 60 days following graft infusion. Median duration of pyrexia was 10 (range 2–49) days. A microbial source was detected in 42% and it was Gram (+) in 86%, Gram (-) in 11% and fungal in 3%. In 16 patients, in dwelling venous catheters were removed due to severe infection. Subsequent to the recovery of the blood parameters, the most prevalent infection was by herpes varicella/zoster in 20; another 17 developed herpes simplex. In total 40/102 were re-hospitalized for pyrexia, which in four cases was of unknown origin. Bacterial infections with Staphylococcus Aureus and S. Epidermitis were seen in 10 and seven patients respectively. CMV was detected in seven patients. Thirteen patients died of sepsis and in 10, it was related to GvHD or graft failure. Another 20 died following recurrence of the malignancy. Overall, 39 patients died and 63% survived at a median DFS of 1992 (range 623–5092) days. We conclude that during the initial neutropenic period the dominant infections are by Gram (+) organisms, often associated with indwelling catheters. Once the BM has recovered, the main morbidity is by viral infections, but Gram+ organisms still remain common bacterial pathogens.Keywords
This publication has 13 references indexed in Scilit:
- CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cellsBone Marrow Transplantation, 2000
- BONE MARROW TRANSPLANTATION DEPLETED OF T CELLS FOLLOWED BY REPLETION WITH INCREMENTAL DOSES OF DONOR LYMPHOCYTES FOR RELAPSING PATIENTS WITH CHRONIC MYELOID LEUKEMIATransplantation, 2000
- IMMUNE RECONSTITUTION AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION DEPLETED OF T CELLSTransplantation, 2000
- Clinical Utility of Blood Cultures Drawn from Indwelling Central Venous Catheters in Hospitalized Patients with CancerAnnals of Internal Medicine, 1999
- Influence of Intestinal Bacterial Decontamination Using Metronidazole and Ciprofloxacin or Ciprofloxacin Alone on the Development of Acute Graft-Versus-Host Disease After Marrow Transplantation in Patients With Hematologic Malignancies: Final Results and Long-Term Follow-Up of an Open-Label Prospective Randomized TrialBlood, 1999
- EX VIVO DEPLETION OF T CELLS FROM BONE MARROW GRAFTS WITH CAMPATH-1 IN ACUTE LEUKEMIATransplantation, 1999
- The Clinical Significance of Positive Blood Cultures in the 1990s: A Prospective Comprehensive Evaluation of the Microbiology, Epidemiology, and Outcome of Bacteremia and Fungemia in AdultsClinical Infectious Diseases, 1997
- Increased risk of infection in marrow transplant patients receiving methylprednisolone for graft-versus-host disease preventionBlood, 1994
- Collection and cryopreservation of human stem and progenitor cells for bone marrow transplantationJournal of Clinical Apheresis, 1991
- Bone-Marrow TransplantationNew England Journal of Medicine, 1975